Procept BioRobotics Corp’s recently made public that its Director Desai Antal Rohit unloaded Company’s shares for reported $1.6 million on Jun 10 ’25. In the deal valued at $63.91 per share,25,000 shares were sold. As a result of this transaction, Desai Antal Rohit now holds 64,363 shares worth roughly $3.19 million.
Then, Desai Antal Rohit sold 25,000 shares, generating $1,584,525 in total proceeds. Upon selling the shares at $63.38, the Director now owns 39,363 shares.
Before that, Desai Antal Rohit sold 25,000 shares. Procept BioRobotics Corp shares valued at $1,537,256 were divested by the Director at a price of $61.49 per share. As a result of the transaction, Desai Antal Rohit now holds 14,363 shares, worth roughly $0.71 million.
Stephens initiated its Procept BioRobotics Corp [PRCT] rating to an Overweight in a research note published on July 09, 2025; the price target was $70. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in early July with a ‘”a Perform”‘ rating. Morgan Stanley began covering PRCT with “an Overweight” recommendation on December 02, 2024. Jefferies started covering the stock on November 14, 2024. It rated PRCT as “a Hold”.
Price Performance Review of PRCT
On Monday, Procept BioRobotics Corp [NASDAQ:PRCT] saw its stock fall -0.72% to $49.6. Over the last five days, the stock has lost -8.29%. Procept BioRobotics Corp shares have fallen nearly -21.67% since the year began. Nevertheless, the stocks have fallen -38.40% over the past one year.
How much short interest is there in Procept BioRobotics Corp?
A steep rise in short interest was recorded in Procept BioRobotics Corp stocks on 2025-07-15, growing by 0.11 million shares to a total of 6.82 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 6.72 million shares. There was a rise of 1.56%, which implies that there is a positive sentiment for the stock.
